ADAP
Adaptimmune Therapeutics
ADAP
ADAP
49 hedge funds and large institutions have $259M invested in Adaptimmune Therapeutics in 2016 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 6 reducing their positions, and 12 closing their positions.
Holders
49
Holders Change
–
Holders Change %
0%
% of All Funds
1.31%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
12
Increased
13
Reduced
6
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Marshall Wace
London,
United Kingdom
| – | – | -140,983 | Closed |
|
52
Point72 Asset Management
Stamford,
Connecticut
| – | – | -130,200 | Closed |
|
|
GAMA
53
Graticule Asia Macro Advisors
New York
| – | – | -50,000 | Closed |
|
|
AFM
54
Anson Funds Management
Dallas,
Texas
| – | – | -30,737 | Closed |
|
|
QSS
55
Quantitative Systematic Strategies
Ponte Vedra Beach,
Florida
| – | – | -24,918 | Closed |
|
56
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | – | -10,844 | Closed |
|
57
UBS Group
Zurich,
Switzerland
| – | – | -5,164 | Closed |
|
58
BlackRock
New York
| – | – | -600 | Closed |
|
59
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | – | -500 | Closed |
|
|
CSS
60
Cubist Systematic Strategies
Stamford,
Connecticut
| – | – | -7 | Closed |
|
61
Citigroup
New York
| $0 | 1 | +1 | New |
|